Roche Molecular Systems, Inc. - Comment

Document ID: FDA-2011-D-0799-0004
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 27 2012, at 12:00 AM Eastern Standard Time
Date Posted: February 13 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: November 28 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: January 27 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80fa7f3b
View Document:  View as format xml

View Comment

See attached file(s) PLEASE NOTE: A previous version of this document was uploaded earlier today. This document had an incorrect date. The date in this current document has been corrected, and is the only change from the previous version.

Attachments:

Roche Molecular Systems, Inc. - Comment FDA-2011-D-0799_HBV_012712_rev01

Title:
Roche Molecular Systems, Inc. - Comment FDA-2011-D-0799_HBV_012712_rev01

View Attachment: View as format pdf

Related Comments

    View All
Total: 6
Plasma Protein Therapeutics Association (PPTA) - Comment
Public Submission    Posted: 02/13/2012     ID: FDA-2011-D-0799-0003

Jan 27,2012 11:59 PM ET
Roche Molecular Systems, Inc. - Comment
Public Submission    Posted: 02/13/2012     ID: FDA-2011-D-0799-0004

Jan 27,2012 11:59 PM ET
America's Blood Centers - Comment
Public Submission    Posted: 02/13/2012     ID: FDA-2011-D-0799-0005

Jan 27,2012 11:59 PM ET
Roche Molecular Systems, Inc. (RMS) - Comment
Public Submission    Posted: 04/17/2012     ID: FDA-2011-D-0799-0006

Jan 27,2012 11:59 PM ET
Viacord Processing Laboratory (VPL) - Comment
Public Submission    Posted: 04/17/2012     ID: FDA-2011-D-0799-0007

Jan 27,2012 11:59 PM ET